E-LIB Suche - Ergebnisse für: Meyers, Daniel E

1

Imaging response to immune checkpoint inhibitors in patient..:

Gupta, Mehul ; Stukalin, Igor ; Meyers, Daniel E....
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

Effectiveness of immune checkpoint inhibitor therapy on bon..:

Abbott, Annalise G. ; Meyers, Daniel E. ; Elmi-Assadzadeh, Golpira...
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Characteristics of clinician input in Canadian funding deci..:

Jenei, Kristina ; Meyers, Daniel E
BMJ Open. 13 (2023) 10 - p. e066378 , 2023

Link: https://doi.org/10.1136/..

4

Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognos..:

Navani, Vishal ; Meyers, Daniel E. ; Ruan, Yibing...
Clinical Lung Cancer. 24 (2023) 3 - p. e152-e159 , 2023

Link: https://doi.org/10.1016/..

5

Development and Validation of a Prognostic Risk Model for P..:

Stukalin, Igor ; Navani, Vishal ; Gupta, Mehul...
The Oncologist. 28 (2023) 9 - p. 812-822 , 2023

Link: https://doi.org/10.1093/..

6

Impact of Performance Status on Survival Outcomes and Healt..:

Meyers, Daniel E. ; Pasternak, Meghann ; Dolter, Samantha...
JTO Clinical and Research Reports. 4 (2023) 4 - p. 100482 , 2023

Link: https://doi.org/10.1016/..

7

Clinical Factors Associated with Long-Term Survival in Meta..:

Goutam, Siddhartha ; Stukalin, Igor ; Ewanchuk, Benjamin...
Current Oncology. 29 (2022) 10 - p. 7695-7704 , 2022

Link: https://doi.org/10.3390/..

8

The Role of Immunotherapy in the Treatment of Malignant Ple..:

Banerji, Shantanu ; Meyers, Daniel E. ; Harlos, Craig.
Current Oncology. 28 (2021) 6 - p. 4542-4552 , 2021

Link: https://doi.org/10.3390/..

9

Evaluation of the modified immune prognostic index to progn..:

Sander, Michael S. ; Stukalin, Igor ; Vallerand, Isabelle A....
Cancer Medicine. 10 (2021) 8 - p. 2618-2626 , 2021

Link: https://doi.org/10.1002/..

10

Effectiveness and Safety of First-Line Pembrolizumab in Old..:

Grosjean, Heidi A. I. ; Dolter, Samantha ; Meyers, Daniel E....
Current Oncology. 28 (2021) 5 - p. 4213-4222 , 2021

Link: https://doi.org/10.3390/..

11

Machine learning for prediction of cutaneous adverse events..:

Lewinson, Ryan T. ; Meyers, Daniel E. ; Vallerand, Isabelle A....
Journal of the American Academy of Dermatology. 84 (2021) 1 - p. 183-185 , 2021

Link: https://doi.org/10.1016/..

12

27995 Evaluation of the modified immune prognostic index to..:

Sander, Michael ; Stukalin, Igor ; Vallerand, Isabelle A....
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB170 , 2021

Link: https://doi.org/10.1016/..

13

Industry payments to US physicians for cancer therapeutics:..:

Meyers, Daniel E. ; Chisamore, Timothy M. ; McInnes, Matthew D.F....
Journal of Cancer Policy. 28 (2021) - p. 100283 , 2021

Link: https://doi.org/10.1016/..

14

Challenges with sex-specific subgroup analyses in oncology ..:

Jenei, Kristina ; Raymakers, Adam ; Meyers, Daniel E..
Journal of Cancer Policy. 30 (2021) - p. 100311 , 2021

Link: https://doi.org/10.1016/..

15

Outcomes of patients with solid tumour malignancies treated..:

Gan, Chun L. ; Stukalin, Igor ; Meyers, Daniel E....
European Journal of Cancer. 151 (2021) - p. 115-125 , 2021

Link: https://doi.org/10.1016/..